This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of London. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Nicholas R Lemoine: Innovator in Cancer Treatment
Introduction
Nicholas R Lemoine is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the development of therapies that utilize modified viruses for therapeutic purposes.
Latest Patents
Nicholas R Lemoine holds a patent titled "Inhibitors of PI3K p-delta 110 for use in delivery of viruses in the treatment of cancer." This invention provides a composition that includes a phosphatidylinositol 3-kinase (PI3K) inhibitor and a modified virus. The composition is designed for separate, subsequent, or simultaneous use in cancer treatment, with the modified virus intended for intravenous administration. He has 1 patent to his name.
Career Highlights
Lemoine is affiliated with the University of London, where he conducts his research and develops his innovative ideas. His work has garnered attention in the scientific community, particularly for its potential impact on cancer therapies.
Collaborations
Some of his notable coworkers include Yaohe Wang and Mark Ferguson. Their collaborative efforts contribute to the advancement of research in the field of cancer treatment.
Conclusion
Nicholas R Lemoine is a key figure in the development of innovative cancer therapies, with a focus on utilizing modified viruses for treatment. His contributions to the field are significant and continue to inspire further research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile